Skip to main content
Clinical Trials/NCT02464813
NCT02464813
Completed
Phase 4

Effect of Pregabalin on Immediate Post-operative and Longterm Pain and Spinal Cord Monitoring in Children Undergoing Instrumented Spinal Surgery.

Turku University Hospital1 site in 1 country64 target enrollmentAugust 1, 2015

Overview

Phase
Phase 4
Intervention
Pregabalin
Conditions
Scoliosis
Sponsor
Turku University Hospital
Enrollment
64
Locations
1
Primary Endpoint
Postoperative pain measured in oxycodone consumption
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study aims to evaluate the incidence of longterm pain after spinal fusion surgery in children and adolescents. In the second part of the study a randomized double-blind clinical trial will be conducted. We compare the effect of pregabalin versus placebo on postoperative pain and oxycodone consumption. We will also be able to evaluate the effect of pregabalin on neurophysiological monitoring during surgery.

Detailed Description

Adolescent idiopathic scoliosis is the most common indication for major surgery during adolescence. Postoperative pain is a major concern in these adolescents with major surgical trauma. Spinal cord monitoring is an essential part of spinal deformity correction, but the effects of pregabalin on these measurements are not known. In order to evaluate the incidence of longterm postoperative pain in children after spinal surgery the first part of our study will be retrospective. We will send a symptom and pain questionnaire to all children, who have been in spinal fusion surgery at our university hospital between the years 2009-2015. The questionnaire will include Oswestry Low Back Pain Questionnaire, pain drawing and SRS-24. The Oswestry Disability Index is currently considered by many as the gold standard for measuring degree of disability and estimating quality of life in a person with low back pain. In the second part of our study a randomized double-blind clinical trial will be conducted comparing the effect of pregabalin and placebo on postoperative pain and oxycodone consumption. In addition the effect of pregabalin on neurophysiological monitoring in adolescents undergoing surgery for spinal deformities will be assessed. Finally, the prevalence of persistent postsurgical pain will be evaluated at 6, 12 and 24 months after surgery. To obtain statistical power of 80% and a type I-error level of 0.05, 60 adolescents (30 in control and 30 in active treatment group) will be recruited according to CONSORT guidelines. The aim of the study is to evaluate the effect of pregabalin given twice preoperatively and for five days postoperatively on postoperative pain. Pain will be measured using visual analogue scale (VAS). Oxycodone administered using patient controlled anesthesia (PCA) will be used for analgesia. Persistent pain at 6, 12 and 24 months will also be evaluated. In addition, the effect of preoperative pregabalin on motor evoked potentials (latency, amplitude, currency needed to evoke potentials) during spinal cord monitoring as well as perioperative EEG findings and on the consumption of anesthetics.

Registry
clinicaltrials.gov
Start Date
August 1, 2015
End Date
October 1, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ilkka Helenius

Division Head

Turku University Hospital

Eligibility Criteria

Inclusion Criteria

  • Adolescent (10-21 years) undergoing spinal fusion for idiopathic scoliosis, spondylolisthesis or Scheuermann kyphosis.
  • Posterior spinal fusion
  • No contraindication for Pregabalin use
  • Written informed consent

Exclusion Criteria

  • Other spinal pathology or other associated medical condition
  • Major neurologic developmental delay
  • Need for anterior surgery or for vertebral column resection.
  • Preoperative opioid use
  • Inability to use PCA

Arms & Interventions

Pregabalin

Pregabalin in hard capsule 2mg/kg rounded up to next 25mg twice daily, max 150mg x 2, for 5 days.

Intervention: Pregabalin

Pregabalin

Pregabalin in hard capsule 2mg/kg rounded up to next 25mg twice daily, max 150mg x 2, for 5 days.

Intervention: Oxycodone

Sugar pill

Same hard capsule and same amount of tablets twice daily for 5 days.

Intervention: Sugar pill

Sugar pill

Same hard capsule and same amount of tablets twice daily for 5 days.

Intervention: Oxycodone

Outcomes

Primary Outcomes

Postoperative pain measured in oxycodone consumption

Time Frame: 0-48h postoperatively

All patients will receive oxycodone as analgesia administered using PCA. The oxycodone consumption will be recorded every 8 h. All adverse effects will be recorded. The oxycodone consumption will be measured in mg/kg/d.

Secondary Outcomes

  • Effect on neurophysiological measurements during spinal surgery(First 24 h.)
  • Effect on incidence of longterm pain(2 years after surgery)

Study Sites (1)

Loading locations...

Similar Trials